113 purchase as supplier for a total of 15 millones (14,951,617.203 ) between 2010 and 2012.
Overcost in MXN
216,961.9 pesos mexicanos
Overcost in %
17.1 %
| Product | Purchases | Total amount | Overcost in MXN | Overcost in % | Period |
|---|---|---|---|---|---|
| LOPERAMIDA | 34 | 261,919.4 MXN | 31,661.2 MXN | 21.7 % | 2010 - 2011 |
| CLIOQUINOL | 18 | 3.7 millones MXN | 11,499.5 MXN | 5.11 % | 2011 - 2011 |
| BROMOCRIPTINA | 18 | 6.2 millones MXN | 34,551.8 MXN | 14.7 % | 2010 - 2012 |
| OXCARBAZEPINA | 7 | 1.4 millones MXN | 132.8 MXN | 0.219 % | 2010 - 2011 |
| METFORMINA | 6 | 1.4 millones MXN | 7,233.6 MXN | 3.55 % | 2011 - 2011 |
| VENLAFAXINA | 5 | 776,177.2 MXN | 20,953.7 MXN | 1.94 % | 2010 - 2011 |
| METRONIDAZOL | 3 | 16,547.7 MXN | 5,972.8 MXN | 57.9 % | 2010 - 2011 |
| FLUOXETINA | 3 | 128,252.8 MXN | 495 MXN | 1.62 % | 2010 - 2011 |
| CITALOPRAM | 3 | 385,814 MXN | 0 MXN | 0 % | 2011 - 2011 |
| ESPIRONOLACTONA | 2 | 41,296.5 MXN | 8,835.3 MXN | 27.2 % | 2012 - 2012 |
1 contract as supplier for a total of 16,327.5 between 2012 and 2012.
Country
Identifiers
RFC: RASG770608LW8
Date updated in QQW
8 de noviembre de 2019
Source(s)
Part of the project
Organization responsible for the import